Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval: significance for the control of sudden cardiac death.
Effects of chronic amiodarone therapy on the circadian rhythmicity and power spectral changes of heart rate and QT intervals from Holter recordings were evaluated in three groups of patients: group 1 baseline (n = 10); group 2, treated for 3 to 6 months (n = 11); and group 3, treated for > 1 year (n = 13). Amiodarone reduced heart rate, which reached steady state at 3 to 6 months; bradycardia was evident during the entire 24 hours. The corrected QT (QTc) interval increased as a function of treatment duration. It was 457 +/- 39, 530 +/- 28 (p < 0.001), and 581 +/- 36 (p < 0.0002) msec for groups 1, 2, and 3, after 6 months, respectively. The circadian rhythmicity of QTc was abolished in group 3. Power spectral analysis showed a tendency for amiodarone to reduce both R-R and QT interval variabilities, suggesting inhibition of autonomic control on the heart by the drug. The effectiveness of amiodarone against ventricular arrhythmias may result in part from the sustained bradycardia in concert with continuous uniform prolongation of myocardial repolarization.
Antimisiaris
M
M
Division of Cardiology, Veterans Affairs Medical Center of West Los Angeles, CA 90073.
Sarma
J S
JS
Schoenbaum
M P
MP
Sharma
P P
PP
Venkataraman
K
K
Singh
B N
BN
D000368:Aged; D000638:Amiodarone / Q000494:pharmacology / Q000627:therapeutic use*; D002940:Circadian Rhythm / Q000187:drug effects*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D015716:Electrocardiography, Ambulatory; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D012815:Signal Processing, Computer-Assisted; D017180:Tachycardia, Ventricular / Q000188:drug therapy*; D013997:Time Factors
D000638:Amiodarone